Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approvalSEATTLE, Feb. 5, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results